187 related articles for article (PubMed ID: 33969170)
1. Standardizing salivary lactoferrin measurements to obtain a robust diagnostic biomarker for Alzheimer's disease.
Bartolome F; Orive G; Carro E
Alzheimers Dement (Amst); 2021; 13(1):e12173. PubMed ID: 33969170
[TBL] [Abstract][Full Text] [Related]
2. Decreased salivary lactoferrin levels are specific to Alzheimer's disease.
González-Sánchez M; Bartolome F; Antequera D; Puertas-Martín V; González P; Gómez-Grande A; Llamas-Velasco S; Herrero-San Martín A; Pérez-Martínez D; Villarejo-Galende A; Atienza M; Palomar-Bonet M; Cantero JL; Perry G; Orive G; Ibañez B; Bueno H; Fuster V; Carro E
EBioMedicine; 2020 Jul; 57():102834. PubMed ID: 32586758
[TBL] [Abstract][Full Text] [Related]
3. Low levels of salivary lactoferrin may affect oral dysbiosis and contribute to Alzheimer's disease: A hypothesis.
Olsen I; Singhrao SK
Med Hypotheses; 2021 Jan; 146():110393. PubMed ID: 33229194
[TBL] [Abstract][Full Text] [Related]
4. Salivary lactoferrin as biomarker for Alzheimer's disease: Brain-immunity interactions.
Bermejo-Pareja F; Del Ser T; Valentí M; de la Fuente M; Bartolome F; Carro E
Alzheimers Dement; 2020 Aug; 16(8):1196-1204. PubMed ID: 32543760
[TBL] [Abstract][Full Text] [Related]
5. Obtaining a Reliable Diagnostic Biomarker for Diabetes Mellitus by Standardizing Salivary Glucose Measurements.
Cui Y; Zhang H; Wang S; Lu J; He J; Liu L; Liu W
Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291544
[TBL] [Abstract][Full Text] [Related]
6. Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin.
Carro E; Bartolomé F; Bermejo-Pareja F; Villarejo-Galende A; Molina JA; Ortiz P; Calero M; Rabano A; Cantero JL; Orive G
Alzheimers Dement (Amst); 2017; 8():131-138. PubMed ID: 28649597
[TBL] [Abstract][Full Text] [Related]
7. Saliva, an easily accessible fluid as diagnostic tool and potent stem cell source for Alzheimer's Disease: Present and future applications.
Reale M; Gonzales-Portillo I; Borlongan CV
Brain Res; 2020 Jan; 1727():146535. PubMed ID: 31669827
[TBL] [Abstract][Full Text] [Related]
8. Salivary Biomarkers for Alzheimer's Disease: A Systematic Review with Meta-Analysis.
Nijakowski K; Owecki W; Jankowski J; Surdacka A
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256241
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers for Alzheimer's Disease in Saliva: A Systematic Review.
Gleerup HS; Hasselbalch SG; Simonsen AH
Dis Markers; 2019; 2019():4761054. PubMed ID: 31191751
[TBL] [Abstract][Full Text] [Related]
10. Salivary Aβ
Fan Z; Li Z; Zhao S; Chen Y; Su Y; Peng G; Luo B
J Neurol; 2023 Apr; 270(4):1945-1954. PubMed ID: 36562850
[TBL] [Abstract][Full Text] [Related]
11. Effect of lactoferrin on taste and smell abnormalities induced by chemotherapy: a proteome analysis.
Wang A; Duncan SE; Lesser GJ; Ray WK; Dietrich AM
Food Funct; 2018 Sep; 9(9):4948-4958. PubMed ID: 30182113
[TBL] [Abstract][Full Text] [Related]
12. Lactoferrin in cerebrospinal fluid and saliva is not a diagnostic biomarker for Alzheimer's disease in a mixed memory clinic population.
Gleerup HS; Jensen CS; Høgh P; Hasselbalch SG; Simonsen AH
EBioMedicine; 2021 May; 67():103361. PubMed ID: 33975253
[TBL] [Abstract][Full Text] [Related]
13. Lactoferrin and Its Detection Methods: A Review.
Zhang Y; Lu C; Zhang J
Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444652
[TBL] [Abstract][Full Text] [Related]
14. Salivary biological biomarkers for Alzheimer's disease.
Liang D; Lu H
Arch Oral Biol; 2019 Sep; 105():5-12. PubMed ID: 31203086
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive screening for Alzheimer's disease by sensing salivary sugar using Drosophila cells expressing gustatory receptor (Gr5a) immobilized on an extended gate ion-sensitive field-effect transistor (EG-ISFET) biosensor.
Lau HC; Lee IK; Ko PW; Lee HW; Huh JS; Cho WJ; Lim JO
PLoS One; 2015; 10(2):e0117810. PubMed ID: 25714733
[TBL] [Abstract][Full Text] [Related]
16. Salivary Proteomics Reveals Significant Changes in Relation to Alzheimer's Disease and Aging.
Contini C; Serrao S; Manconi B; Olianas A; Iavarone F; Bizzarro A; Masullo C; Castagnola M; Messana I; Diaz G; Cabras T
J Alzheimers Dis; 2022; 89(2):605-622. PubMed ID: 35912740
[TBL] [Abstract][Full Text] [Related]
17. A Systematic Review on the Feasibility of Salivary Biomarkers for Alzheimer's Disease.
Bouftas M
J Prev Alzheimers Dis; 2021; 8(1):84-91. PubMed ID: 33336229
[TBL] [Abstract][Full Text] [Related]
18. Investigation of Whole and Glandular Saliva as a Biomarker for Alzheimer's Disease Diagnosis.
Cui Y; Zhang H; Zhu J; Liao Z; Wang S; Liu W
Brain Sci; 2022 May; 12(5):. PubMed ID: 35624982
[TBL] [Abstract][Full Text] [Related]
19. Aβ42 as a Biomarker of Alzheimer's Disease: Is Saliva a Viable Alternative to Cerebrospinal Fluid?
Boschi S; Roveta F; Grassini A; Marcinnò A; Cermelli A; Ferrandes F; Rainero I; Rubino E
Brain Sci; 2022 Dec; 12(12):. PubMed ID: 36552188
[TBL] [Abstract][Full Text] [Related]
20. A pilot study on the effect of lactoferrin on Alzheimer's disease pathological sequelae: Impact of the p-Akt/PTEN pathway.
Mohamed WA; Salama RM; Schaalan MF
Biomed Pharmacother; 2019 Mar; 111():714-723. PubMed ID: 30611996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
